Novo Nordisk A/S Common Stock (NVO)
Interest Expense
kr 1.50B
Quarterly · Period ending: · DKK
NVO Interest Expense
Latest reportedkr 1.50B DKKperiod ending
Latest reportedkr 1.50B DKKperiod ending
NVO Quarterly Interest Expense · DKK (kr 0.00 → kr 1.50B)
Quarterly interest expense
High-resolution chart · PNG
NVO interest expense history
Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Interest Expense (DKK) |
|---|---|
| 1,500,000,000 | |
| 3,499,000,000 | |
| 0 | |
| 0 | |
| 4,958,000,000 | |
| 5,183,000,000 | |
| 5,093,000,000 | |
| 821,000,000 | |
| 1,562,000,000 | |
| 2,074,000,000 | |
| 916,000,000 | |
| 2,168,000,000 | |
| 281,000,000 | |
| 1,122,000,000 | |
| 730,501,000 | |
| 3,725,000,000 | |
| 3,252,000,000 | |
| 1,438,000,000 | |
| 781,298,000 | |
| 927,000,000 | |
| 0 | |
| 797,000,000 | |
| 0 | |
| 279,000,000 | |
| 519,000,000 | |
| 1,298,000,000 | |
| 0 | |
| 829,000,000 | |
| 1,322,000,000 | |
| 1,030,000,000 | |
| 0 | |
| 675,000,000 | |
| 745,000,000 | |
| 37,000,000 | |
| 0 | |
| 26,000,000 | |
| 1,164,000,000 | |
| 744,000,000 | |
| 0 | |
| 119,000,000 | |
| 12,000,000 | |
| 379,000,000 | |
| 0 | |
| 1,853,000,000 | |
| 1,934,000,000 | |
| 1,657,000,000 | |
| 0 | |
| 441,000,000 | |
| 140,000,000 | |
| 318,000,000 | |
| 0 | |
| 111,000,000 | |
| 267,000,000 | |
| 108,000,000 | |
| 0 | |
| 505,000,000 | |
| 856,000,000 | |
| 375,000,000 | |
| 272,000,000 | |
| 308,000,000 | |
| 167,000,000 | |
| 212,000,000 | |
| 810,000,000 | |
| 477,000,000 | |
| 575,000,000 | |
| 195,000,000 | |
| 283,000,000 | |
| 209,000,000 | |
| 361,000,000 | |
| 412,000,000 | |
| 0 | |
| 66,000,000 | |
| 0 | |
| 368,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |